Danimer Scientific, Inc.
Materials · Plastic Materials, Synth Resins & Nonvulcan Elastomers · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
| Revenue | $46.7M | $53.2M | $58.7M | $47.3M | $32.3M |
| Operating income | −$125.6M | −$187.4M | −$99.5M | −$15.7M | −$18.1M |
| Net income | −$155.5M | −$179.8M | −$60.1M | −$12.6M | −$19.5M |
| Total assets | $698.1M | $712.3M | $838.6M | $546.2M | $144.6M |
| Total liabilities | $420.1M | $334.7M | $338.3M | $107.3M | $128.0M |
| Equity | $278.0M | $377.6M | $500.3M | $438.9M | $16.6M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 101.9M | 100.8M | 88.3M | 84.5M | 25.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −269.1%
- Net margin
- −333.0%
- Return on equity
- −55.9%
- Return on assets
- −22.3%
- Return on capital (ROCE)
- −18.4%
- Liabilities / assets
- 60.2%
- Debt / equity
- 1.51×
- Book value / share
- $2.73
- Revenue growth (YoY)
- −12.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -1.77distress
- Accruals / assets
- −15.5%clean
- Piotroski F-Score
- 4/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Kmissed a reporting deadline ↗Mar 2, 2022
- NT 10-Qmissed a reporting deadline ↗May 18, 2021
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Armistice Capital, LlcPassive (13G)May 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Bankruptcy or receivership · Debt acceleration / triggering event · Other material eventMar 18, 2025
- Entered a material agreementFeb 28, 2025
- Entered a material agreement · Debt acceleration / triggering eventFeb 11, 2025
- Delisting / listing-standard notice · Regulation FD disclosureDec 31, 2024
- Entered a material agreement · Terminated a material agreement · New financial obligation · Debt acceleration / triggering event · Regulation FD disclosureDec 17, 2024
- Director / officer changeDec 13, 2024
- Director / officer changeDec 12, 2024
- Director / officer changeDec 3, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.